| 2025-12-23 |
详情>>
股本变动：
变动后总股本1631.24万股
变动原因 ▼▲
- 原因：
- Common Stock offered 1,922,159 shares by the company
|
| 2025-12-10 |
详情>>
业绩披露：
2026年中报每股收益-0.47美元,归母净利润-656万美元,同比去年增长-2.06%
|
| 2025-09-15 |
详情>>
业绩披露：
2026年一季报每股收益-0.15美元,归母净利润-207.75万美元,同比去年增长51.97%
|
| 2025-08-09 |
详情>>
内部人交易：
NORMAN LUKE ANTHONY共交易2笔
|
| 2025-07-29 |
详情>>
业绩披露：
2025年年报每股收益-1.8美元,归母净利润-2055.91万美元,同比去年增长-198.07%
|
| 2025-03-17 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.15美元,归母净利润-1278.98万美元,同比去年增长-164.32%
|
| 2025-03-06 |
股东大会：
将于2025-04-28召开股东大会
会议内容 ▼▲
- 1.To elect the five nominees named in this proxy statement to serve on the Board of Directors (the “Board of Directors” or the “Board”) until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified (the “Election of Directors Proposal”).
2.To ratify the appointment of Marcum LLP as our independent registered public accountant for the fiscal year ending April 30, 2025 (the “Auditor Ratification Proposal”).
3.To approve, by a non-binding advisory vote, the compensation of our named executive officers, as described in this proxy statement (the “Say-on-Pay Proposal”).
4.To approve, by a non-binding advisory vote, the frequency of future advisory votes on the compensation of our named executive officers, as described in this proxy statement (the “Say-on-Pay Frequency Proposal”).
|
| 2024-12-16 |
详情>>
业绩披露：
2025年中报每股收益-0.6美元,归母净利润-642.78万美元,同比去年增长-103.86%
|
| 2024-09-16 |
详情>>
业绩披露：
2025年一季报每股收益-0.4美元,归母净利润-432.53万美元,同比去年增长-49.42%
|
| 2024-07-29 |
详情>>
业绩披露：
2024年年报每股收益-0.74美元,归母净利润-689.75万美元,同比去年增长9.41%
|
| 2024-03-21 |
股东大会：
将于2024-04-26召开股东大会
会议内容 ▼▲
- 1.To elect the five (5) nominees named in this proxy statement to serve on the Board of Directors (the “Board of Directors” or the “Board”) until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified (the “Election of Directors Proposal”).
2.To ratify the appointment of Marcum LLP as our independent registered public accountant for the fiscal year ending April 30, 2024 (the “Auditor Ratification Proposal”).
|
| 2024-03-18 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.52美元,归母净利润-483.88万美元,同比去年增长15.64%
|
| 2023-12-15 |
详情>>
业绩披露：
2024年中报每股收益-0.34美元,归母净利润-315.31万美元,同比去年增长17.93%
|
| 2023-09-14 |
详情>>
业绩披露：
2024年一季报每股收益-0.31美元,归母净利润-289.47万美元,同比去年增长-48.8%
|
| 2022-10-26 |
股东大会：
将于2022-12-16召开股东大会
会议内容 ▼▲
- 1.To elect the six (6) nominees named in this proxy statement to serve on the Board of Directors (the “Board of Directors” or the “Board”) until the 2023 Annual Meeting of Stockholders or until their successors are duly elected and qualified (the “Election of Directors Proposal”).
2.To ratify the appointment of Marcum LLP as our independent registered public accountant for the fiscal year ending April 30, 2023 (the “Auditor Ratification Proposal”).
3.To approve, by a non-binding advisory vote, the compensation of our named executive officers, as described in this proxy statement (the “Say-on-Pay Proposal”).
4.To approve an amendment to the Company’s 2020 Stock Incentive Plan (the “Plan Proposal”).
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-09 |
股东大会：
将于2021-09-20召开股东大会
会议内容 ▼▲
- 1.To elect the five (5) nominees named in this proxy statement to serve on the Board of Directors (the “Board of Directors” or the “Board”) until the 2022 Annual Meeting of Stockholders or until their successors are duly elected and qualified (the “Election of Directors Proposal”).
2.To ratify the appointment of Marcum LLP as our independent registered public accountant for the fiscal year ending April 30, 2022 (the “Auditor Ratification Proposal”).
|
| 2020-09-23 |
股东大会：
将于2020-10-27召开股东大会
会议内容 ▼▲
- 1.To approve, pursuant to Nasdaq listing rule 5635(a), of the issuance of shares of our common stock upon conversion of Series H Convertible Preferred Stock, par value $0.001 per share (the “Series H Preferred Stock”) in excess of 20% of our common stock outstanding (the “Nasdaq Rule 5635(a) Proposal”).
2.To approve, pursuant to Nasdaq listing rules 5635(a) and 5635(d), of the potential issuance of shares of our common stock upon (i) the conversion of Series I Convertible Preferred Stock, par value $0.001 per share (the “Series I Preferred Stock”) in excess of 20% of our common stock outstanding and (ii) the exercise of certain warrants (the “Private Warrants”) in excess of 20% of our common stock outstanding, in each case, issued in a private placement (the “Nasdaq Rule 5635(d) Proposal” and together with the Nasdaq Rule 5635(a) Proposal, the “Nasdaq Proposals” ).
3.To elect the nominees named in this proxy statement to serve on the Board of Directors (the “Board of Directors” or the “Board”) until the 2021 Annual Meeting of Stockholders or until their successors are duly elected and qualified (the “Election of Directors Proposal”).
4.To approve the amendment to the U.S. Gold Corp. 2020 Stock Incentive Plan to increase the total number of shares of common stock authorized for issuance under such plan by 836,385, to a total of 1,167,095 shares (the “Plan Amendment Proposal”).
5.To ratify the appointment of Marcum LLP as our independent registered public accountant for the fiscal year ending April 30, 2021 (the “Auditor Ratification Proposal”).
|
| 2020-09-23 |
股东大会：
将于2020-11-09召开股东大会
会议内容 ▼▲
- 1.To approve, pursuant to Nasdaq listing rule 5635(a), of the issuance of shares of our common stock upon conversion of Series H Convertible Preferred Stock, par value $0.001 per share (the “Series H Preferred Stock”) in excess of 20% of our common stock outstanding (the “Nasdaq Rule 5635(a) Proposal”).
2.To approve, pursuant to Nasdaq listing rules 5635(a) and 5635(d), of the potential issuance of shares of our common stock upon (i) the conversion of Series I Convertible Preferred Stock, par value $0.001 per share (the “Series I Preferred Stock”) in excess of 20% of our common stock outstanding and (ii) the exercise of certain warrants (the “Private Warrants”) in excess of 20% of our common stock outstanding, in each case, issued in a private placement (the “Nasdaq Rule 5635(d) Proposal” and together with the Nasdaq Rule 5635(a) Proposal, the “Nasdaq Proposals” ).
3.To elect the nominees named in this proxy statement to serve on the Board of Directors (the “Board of Directors” or the “Board”) until the 2021 Annual Meeting of Stockholders or until their successors are duly elected and qualified (the “Election of Directors Proposal”).
4.To approve the amendment to the U.S. Gold Corp. 2020 Stock Incentive Plan to increase the total number of shares of common stock authorized for issuance under such plan by 836,385, to a total of 1,167,095 shares (the “Plan Amendment Proposal”).
5.To ratify the appointment of Marcum LLP as our independent registered public accountant for the fiscal year ending April 30, 2021 (the “Auditor Ratification Proposal”).
|
| 2020-03-26 |
复牌提示：
2020-03-26 09:30:42 停牌，复牌日期 2020-03-26 09:40:42
|
| 2020-03-20 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2019-08-15 |
股东大会：
将于2019-09-18召开股东大会
会议内容 ▼▲
- 1.To elect the nominees named in this proxy statement to serve on the Board of Directors (the “Board of Directors” or the “Board”) until the 2020 Annual Meeting of Stockholders or until their successors are duly elected and qualified (the “Election of Directors Proposal”).
2.To ratify the appointment of KBL, LLP as our independent registered public accountant for the fiscal year ending April 30, 2020 (the “Auditor Ratification Proposal”).
3.To approve, by a non-binding advisory vote, the compensation of our named executive officers, as described in this proxy statement (the “Say-on-Pay Proposal”).
4.To approve, by a non-binding advisory vote, the frequency of future advisory votes on the compensation of our named executive officers, as described in this proxy statement (the “Say-on-Pay Frequency Proposal”).
5.To adopt the Company’s 2020 Stock Incentive Plan (the “Plan Proposal”).
6.To approve an amendment of our articles of incorporation to effect a reverse stock split at a ratio not less than 1-for-2 and not greater than 1-for-10, with the exact ratio to be set within that range at the discretion of the Board of Directors before September 18, 2020 without further approval or authorization of our stockholders (the “Reverse Stock Split Proposal”). The Board may alternatively elect to abandon such proposed amendment and not effect the reverse stock split authorized by stockholders, in its sole discretion.
|
| 2018-08-17 |
股东大会：
将于2018-09-13召开股东大会
会议内容 ▼▲
- 1.Elect as directors the nominees named in the proxy statement;
2.Approve an amendment to the Company’s Articles of Incorporation, as amended, to implement a reverse stock split of the Company’s issued and outstanding common stock at a ratio of not less than 1 for 2 and not more than 1 for 10, within the discretion of the Board of Directors, at any time prior to September 13, 2019;
3.Approve the issuance of securities in one or more non-public offerings where the maximum discount at which securities will be offered will be equivalent to a discount of 30% below market price of our common stock in accordance with Nasdaq Marketplace Rule 5635(d);
4.Hold an advisory vote to approve the compensation of the Company’s executive officers;
5.Ratify the retention of KBL LLP as the Company’s independent registered public accounting firm for the fiscal year ending April 30, 2019;
6.Transact such other business as may properly come before the meeting or any adjournments.
|
| 2017-07-12 |
股东大会：
将于2017-07-31召开股东大会
会议内容 ▼▲
- 1.Elect as directors the nominees named in the proxy statement;
2.To ratify the appointment of Marcum LLP as our independent public accountant for the fiscal year ending April 30, 2018;
3.To advise us as to whether you approve the compensation of our named executive officers (Say-on-Pay);
4.To approve the Company’s 2017 Equity Incentive Plan, including the reservation of 1,650,000 shares of common stock thereunder;
5.To transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof.
|
| 2017-05-05 |
详情>>
拆分方案：
每4.0000合并分成1.0000股
|
| 2017-03-03 |
股东大会：
将于2017-03-30召开股东大会
会议内容 ▼▲
- 1. Approve the Merger and the issuance of an aggregate of (i) up to 45,880,820 shares of common stock, par value $0.001 per share (the “Common Stock”) of the Company (including shares of Common Stock issuable upon conversion of our newly designated Series C Convertible Preferred Stock, par value $0.001 per share (the “Series C Preferred Stock”), (ii) options to purchase up to 925,833 shares of the Company’s Common Stock at an exercise price equal to $0.90 per share and (iii) warrants to purchase up to 1,809,436 shares of the Company’s Common Stock at an exercise price of $0.66 per share, (collectively, the “Merger Consideration”) as consideration for the acquisition of USG in accordance with The NASDAQ Stock Market Rules (“Stock Market Rules”);
2. Approve a certificate of amendment to our Articles of Incorporation to increase our authorized number of shares of Common Stock and preferred stock, par value $0.01 per share (the “Preferred Stock”) to 200,000,000 shares from 54,000,000 shares and 50,000,000 shares from 5,000,000 shares, respectively;
3. Grant the Board of Directors the authority, in its sole discretion, to approve an amendment to the Company's Articles of Incorporation to effect a reverse stock split (the “Reverse Split”) of our issued and outstanding Common Stock by a ratio of not less than 1-for-2 and not more than 1-for-10 at any time prior to March 30, 2018, with the exact ratio to be set at a whole number within this range as determined by the Board of Directors;
4. Transact such business as may properly come before the meeting or any adjournments.
|
| 2016-07-08 |
详情>>
拆分方案：
每3.0000合并分成1.0000股
|
| 2015-10-26 |
股东大会：
将于2015-12-03召开股东大会
会议内容 ▼▲
- 1.Elect as directors the nominees named in the proxy statement;
2.Ratify the retention of Anton & Chia LLP as the Company’s independent registered public accounting firm for the fiscal year ending April 30, 2016;
3.Hold an advisory vote to approve the compensation of the Company’s executive officers;
4.Approve amendments to the 2014 Equity Incentive Plan;
5.Approve an amendment to the Company’s Restated Certificate of Incorporation to change the par value of the Company’s common stock from $1.00 per share to $0.001 per share;
6.Approve the reincorporation of the Company to the State of Nevada;
7.Approve an amendment to the Company’s Restated Certificate of Incorporation to implement a Reverse Stock Split of the Company’s common stock at a ratio of not less than 1 for 2 and not more than 1 for 10, within the discretion of the Board of Directors, at any time prior to December 3, 2016;
8.Approve the issuance of securities in one or more non-public offerings where the maximum discount at which securities will be offered will be equivalent to a discount of 30% below market price of our common stock in accordance with Nasdaq Marketplace Rule 5635(d);
9.To approve a certificate of amendment to the Company’s Restated Certificate of Incorporation to increase the authorized number of shares of common stock and preferred stock to 100,000,000 shares from 54,000,000 shares and 15,000,000 shares from 5,000,000 shares, respectively;
10.Transact such other business as may properly come before the meeting or any adjournments.
|